SciELO - Scientific Electronic Library Online

 
vol.16 número2Cirugía transeptoesfenoidal en adenomas hipofisarios productores de prolactinaCirugía transnasal transesfenoidal endoscópica en afecciones de región selar índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Endocrinología

versión On-line ISSN 1561-2953

Resumen

MARRERO RODRIGUEZ, María Teresa; RODRIGUEZ GONZALEZ, Julio César  y  ALAVEZ MARTIN, Ernesto. Ophthalmological evolution in hyperthyroid patients treated with radioactive iodine. Rev Cubana Endocrinol [online]. 2005, vol.16, n.2. ISSN 1561-2953.

This study was aimed at analyzing the ophthalmolgical evolution in hyperthyroid patients treated with radioactive iodine. 100 patients (88 females and 12 males) from the thyroid department of the National Institute of Endocrinology with clinical and biochemical diagnosis of hyperthyroidism and with a mean age of 40 ± 10 years old, were studied. These patients underwent a treatment with radioactive iodine at a dose of 80 m Ci/g of thyroid tissue. A bilateral ophthalmometry was performed to each patient before the treatment and 12 months after it. Mean ophthalmometry of the right eye was 14.51 ± 2.86 mm before the treatment and 13.92 ± 2.83 mm after the treatment, whereas for the left eye it was 14.98 ± 2.91 mm and 14.27 ± 2.83 mm , respectively. Taking into account the results of the ophthalmometry, we concluded that the use of radioactive iodine in the treatment of hyperthyroid patients had no negative results on the ophthalmological evolution of the studied patients.

Palabras clave : Ophthalmopathy; exophthalmus; hyperthyroidism; radioactive iodine.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons